GainMedApexium
A finished professional serum-and-cream system built on the Apexium EX3-MP Complex™ — plant-derived exosomes paired with a multi-peptide + collagen matrix. Documented on 28-day human evaluation.
- EX3-MP peptide matrix + plant-derived exosome carrier
- Skin moisture +72.11% · TEWL −16.36% at 28 days (p<0.001)
- Eye-area wrinkle area −10.22%; 93.94% rated suitable for sensitive skin
- Animal-free, non-immunogenic collagen · GMP-certified
- Classification
- Finished cosmetic (professional skincare system)
- Intended use
- Professional, appearance-focused skincare regimen
- Not intended for
- Injection or medical treatment
- Complex
- Apexium EX3-MP Complex™ — plant-derived exosomes + collagen-peptide matrix
- Actives
- Loaded exosomes · Type IIIα human-homologous collagen · bioactive collagen peptides · hyaluronic acid · Natural Moisturizing Factors
- Peptides
- Acetyl Hexapeptide-8 · Dipeptide Diaminobutyroyl Benzylamide Diacetate · Palmitoyl Peptides
- Mechanism
- Activation (serum) → Rejuvenation → Protection (cream)
- Clinical study
- 28-day human evaluation on sensitive, dry, photoaged skin
- Provenance
- Animal-free · non-immunogenic · GMP-certified facility
- Formats
- Serum 40 ml · Cream 50 g · Set
- Marking
- EX3-MP Complex · Made in USA
- Storage & handling
- Provided with product documentation
- Shelf life
- Stated on pack and documentation
- Minimum order
- On request by market
- Lead time
- Confirmed with each quote
Documented on skin,
measured to the biomarker.
Subjects with sensitive, dry, or photoaged skin used the Apexium regimen for 28 days. Endpoints were captured with corneometry, TEWL, colorimetry, and image analysis; molecular effect was profiled by biomarker upregulation.
28-day human study
Sensitive · dry · photoaged
Measured benefits
Molecular
upregulation.
In-vitro profiling on human keratinocytes and fibroblasts. Apexium significantly upregulated the essential proteins that keep the barrier intact and the dermis structured.
- Loricrin (LOR)
- ↑ 90.91% — cornified envelope; strengthens the barrier
- Filaggrin (FLG)
- ↑ 22.73% — produces Natural Moisturizing Factors for hydration
- Transglutaminase-1 (TGM1)
- ↑ 113.89% — cross-links barrier proteins for structural integrity
- CD44
- ↑ 89.19% — enhances hyaluronic-acid utilization for plumpness
- Type I & IV collagen
- ↑ 36.76% – 58.18% — rebuilds dermal structure and strengthens the DEJ
Endpoints are illustrative of the referenced study. Individual response varies with age, skin type, and adherence. Not a therapeutic claim.
Documentation
available.
Request any of the following for Apexium. We share what applies to your market and intended use.
- Product overviewon request
- Ingredient / INCI profileon request
- Formulation contexton request
- Usage guidanceon request
Cosmetic classification
Apexium is a finished cosmetic for professional skincare. It is for external use on intact skin and is not intended to diagnose, treat, cure, or prevent any disease. Claims are limited to appearance and skin-conditioning benefits, and market registration requirements vary by country.
Before & after,
on the record.
Documented on a single subject after 90 days of the Apexium regimen — serum plus cream, twice daily — under matched studio lighting.
ExoCura
Professional & Aesthetic
Human UMSC-derivedExoCell
Clinical Materials
Stem-cell materialsWJ-MSCs
Clinical Materials
Request Apexium.
Tell us your market and intended use. A specialist replies within one business day.